Periodic Reporting for period 3 - RuCat (New Horizons in C–H Activation: the ‘Real-World Molecules’ Challenge)

A 2018 joint pharma report identified organic synthesis as one of the major bottlenecks in drug discovery today. In the highly competitive discovery environments, only fast-to-synthesise molecules are targeted, which has led to only a small portion of the chemical shape space...